Pyrotinib: A promising Tyrosine Kinase Inhibitor for treating Breast Cancer. Molecular Medicine Communications, [S. l.], v. 4, n. 01, p. 43–57, 2024. DOI: 10.55627/mmc.004.001.0553. Disponível em: https://rootspress.org/journals/index.php/MMC/article/view/553. Acesso em: 16 sep. 2024.